News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
644,849 Results
Type
Article (61300)
Company Profile (69)
Press Release (583480)
Multimedia
Podcasts (59)
Webinars (13)
Section
Business (173699)
Career Advice (2729)
Deals (32410)
Drug Delivery (97)
Drug Development (76863)
Employer Resources (150)
FDA (14932)
Job Trends (13884)
News (304872)
Policy (28936)
Tag
Academia (2893)
Academic (2)
Accelerated approval (6)
Adcomms (22)
Allergies (88)
Alliances (43169)
ALS (88)
Alzheimer's disease (1320)
Antibody-drug conjugate (ADC) (109)
Approvals (14948)
Artificial intelligence (264)
Autoimmune disease (23)
Automation (15)
Bankruptcy (290)
Best Places to Work (10853)
BIOSECURE Act (16)
Biosimilars (101)
Biotechnology (51)
Bladder cancer (78)
Brain cancer (27)
Breast cancer (273)
Cancer (2182)
Cardiovascular disease (165)
Career advice (2312)
Career pathing (33)
CAR-T (154)
Cell therapy (430)
Cervical cancer (20)
Clinical research (62503)
Collaboration (785)
Company closure (1)
Compensation (326)
Complete response letters (20)
COVID-19 (2571)
CRISPR (43)
C-suite (260)
Cystic fibrosis (100)
Data (2151)
Decentralized trials (2)
Denatured (25)
Depression (43)
Diabetes (252)
Diagnostics (6160)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (39)
Drug discovery (113)
Drug pricing (97)
Drug shortages (23)
Duchenne muscular dystrophy (86)
Earnings (60115)
Editorial (39)
Employer branding (18)
Employer resources (132)
Events (94427)
Executive appointments (760)
FDA (16186)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (748)
Gene editing (109)
Generative AI (20)
Gene therapy (299)
GLP-1 (665)
Government (4460)
Grass and pollen (6)
Guidances (64)
Healthcare (18205)
Huntington's disease (19)
IgA nephropathy (25)
Immunology and inflammation (108)
Indications (28)
Infectious disease (2704)
Inflammatory bowel disease (136)
Inflation Reduction Act (8)
Influenza (53)
Intellectual property (96)
Interviews (526)
IPO (14785)
IRA (38)
Job creations (3416)
Job search strategy (1941)
Kidney cancer (10)
Labor market (30)
Layoffs (503)
Leadership (22)
Legal (6431)
Liver cancer (69)
Lung cancer (305)
Lymphoma (145)
Machine learning (7)
Management (53)
Manufacturing (276)
MASH (63)
Medical device (12652)
Medtech (12657)
Mergers & acquisitions (18203)
Metabolic disorders (632)
Multiple sclerosis (77)
NASH (13)
Neurodegenerative disease (84)
Neuropsychiatric disorders (26)
Neuroscience (1837)
NextGen: Class of 2025 (6374)
Non-profit (4317)
Now hiring (12)
Obesity (321)
Opinion (232)
Ovarian cancer (71)
Pain (91)
Pancreatic cancer (79)
Parkinson's disease (141)
Partnered (21)
Patents (234)
Patient recruitment (112)
Peanut (50)
People (59553)
Pharmaceutical (20)
Pharmacy benefit managers (15)
Phase I (19683)
Phase II (27572)
Phase III (20129)
Pipeline (1142)
Policy (125)
Postmarket research (2470)
Preclinical (8405)
Press Release (67)
Prostate cancer (107)
Psychedelics (27)
Radiopharmaceuticals (249)
Rare diseases (360)
Real estate (5986)
Recruiting (61)
Regulatory (20100)
Reports (33)
Research institute (2396)
Resumes & cover letters (405)
Rett syndrome (5)
RNA editing (3)
RSV (35)
Schizophrenia (68)
Series A (131)
Series B (86)
Service/supplier (9)
Sickle cell disease (51)
Special edition (10)
Spinal muscular atrophy (146)
Sponsored (29)
Startups (3343)
State (1)
Stomach cancer (9)
Supply chain (54)
Tariffs (26)
The Weekly (32)
Vaccines (664)
Venture capitalists (34)
Weight loss (202)
Women's health (30)
Worklife (19)
Date
Today (128)
Last 7 days (851)
Last 30 days (2458)
Last 365 days (30477)
2025 (10153)
2024 (32279)
2023 (36338)
2022 (46622)
2021 (51566)
2020 (50712)
2019 (44788)
2018 (34068)
2017 (30724)
2016 (30066)
2015 (35455)
2014 (28415)
2013 (24975)
2012 (26237)
2011 (26487)
2010 (24954)
Location
Africa (876)
Alabama (54)
Alaska (6)
Arizona (171)
Arkansas (14)
Asia (38061)
Australia (6847)
California (5556)
Canada (1855)
China (487)
Colorado (248)
Connecticut (259)
Delaware (140)
Europe (88808)
Florida (848)
Georgia (199)
Idaho (56)
Illinois (548)
India (25)
Indiana (279)
Iowa (10)
Japan (153)
Kansas (95)
Kentucky (24)
Louisiana (10)
Maine (61)
Maryland (828)
Massachusetts (4017)
Michigan (222)
Minnesota (338)
Mississippi (2)
Missouri (87)
Montana (29)
Nebraska (23)
Nevada (57)
New Hampshire (61)
New Jersey (1639)
New Mexico (29)
New York (1629)
North Carolina (956)
North Dakota (9)
Northern California (2407)
Ohio (194)
Oklahoma (15)
Oregon (36)
Pennsylvania (1235)
Puerto Rico (12)
Rhode Island (31)
South America (1178)
South Carolina (17)
South Dakota (1)
Southern California (2126)
Tennessee (95)
Texas (847)
United States (21245)
Utah (172)
Virginia (143)
Washington D.C. (50)
Washington State (515)
West Virginia (3)
Wisconsin (60)
644,849 Results for "university of geneva".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Dandelion Science and the Wyss Center Geneva announce AI partnership to generate non-invasive brain therapies
The Wyss Center for Bio and Neuroengineering in Geneva and Dandelion Science are excited to announce a partnership focused on a cutting-edge generative AI neuromodulation platform that could speed the development of safe, non-invasive ways of treating neurodegenerative and neuropsychiatric disorders.
June 11, 2024
·
3 min read
Antion Biosciences announces development of safety-enhanced and off-the-shelf CAR T-cells for autoimmune diseaseAiming for a best-in-class solution to treat and cure B-cell driven autoimmune diseases
Antion Biosciences, a Geneva-based cell and gene therapy company developing “off-the-shelf” cell therapies, announces the development of next generation anti-CD19 chimeric antigen receptor T-cells for B-cell driven autoimmune diseases.
May 22, 2024
·
2 min read
Biotech Bay
Biotricity’s Founder & CEO Waqaas Al-Siddiq to Present at World Heart Summit May 19-21 in Geneva, Switzerland
Biotricity Inc. announced that its Founder & CEO Waqaas Al-Siddiq will be speaking at the World Heart Summit 2023 taking place in Geneva, Switzerland on May 19-21.
May 10, 2023
·
5 min read
KBI Biopharma, Inc. Secures Swissmedic Regulatory Establishment License for State-of-the-Art Mammalian Cell Manufacturing Facility in Geneva
KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced its recently expanded, state-of-the-art Geneva mammalian cell manufacturing facility has obtained a Swissmedic regulatory establishment license.
December 20, 2022
·
2 min read
ONO Enters into a University-Wide, Research Alliance Agreement with Harvard University
Ono Pharmaceutical Co., Ltd. announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University aiming at validating novel therapeutic targets.
March 11, 2024
·
3 min read
RELIEF THERAPEUTICS Holding SA Announces Results of Annual General Meeting
RELIEF THERAPEUTICS Holding SA announces the results of its annual general meeting (AGM) of shareholders, which took place in Geneva today.
June 27, 2024
·
3 min read
Business
Wyss Center Geneva Appoints Erwin Böttinger as new Chief Executive Officer
The Executive Board of the Wyss Center for Bio and Neuroengineering, a non-profit research center, is pleased to announce the appointment of Prof. Dr. med. Erwin Böttinger as its new Chief Executive Officer.
April 3, 2023
·
3 min read
KBI Biopharma and Selexis Hold Joint Ribbon Cutting of the Expanded State-of-the-Art Facility in Geneva, Switzerland
KBI Biopharma SA and Selexis SA, both JSR Life Sciences companies, held a joint ribbon-cutting ceremony yesterday at their new state-of-the-art facility in Geneva, Switzerland.
July 6, 2022
·
5 min read
Layoffs
Astellas Cuts 24 Universal Cells Roles in Seattle, Transfers 12 to Japan
Astellas is opening a second location of Universal Cells, its wholly owned subsidiary, at a research campus in Japan and transferring 12 roles from Universal’s Seattle location.
October 10, 2024
·
1 min read
·
Angela Gabriel
RELIEF THERAPEUTICS Holding SA Announces Results of Extraordinary General Meeting
RELIEF THERAPEUTICS Holding SA announces the results of the extraordinary general meeting of shareholders, which took place in Geneva , Friday, April 26, 2024.
April 26, 2024
·
4 min read
1 of 64,485
Next
